Skip to main content

Passage BIO Inc

For the period ended Mar 31, 2024. Filed May 14, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 14, 2024

PASG$3.43-13.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

​​​​
​ · ​ · Page
PART I.​FINANCIAL INFORMATION4
Item 1.​Interim Financial Statements (Unaudited)4
​​Balance Sheets4
​​Statements of Operations and Comprehensive Loss5
​​Statements of Stockholders’ Equity6
​​Statements of Cash Flows7
​​Notes to Unaudited Interim Financial Statements8
Item 2.​Management’s Discussion and Analysis of Financial Condition and Results of Operations24
Item 3.​Quantitative and Qualitative Disclosures About Market Risk36
Item 4.​Controls and Procedures36
PART II.​OTHER INFORMATION37
Item 1.​Legal Proceedings37
Item 1A.​Risk Factors37
Item 2.​Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities89
Item 3.​Defaults Upon Senior Securities89
Item 4.​Mine Safety Disclosures89
Item 5.​Other Information89
Item 6.​Exhibits90
Signatures92
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.